Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Lunai Bioworks Inc (LNAI)

Lunai Bioworks Inc (LNAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Lunai Bioworks (NASDAQ: LNAI) and Geneial Sign LOI to Build Rare Disease Patient Cohorts for Pharma Partnerships PR Newswire - Wed Apr 15, 8:10AM CDT

Collaboration converts patient-led data into trial-ready cohorts to support drug development, commercial partnerships, and revenue-generating opportunities.

LNAI : 0.3040 (-5.85%)
Lunai Bioworks (NASDAQ: LNAI) Secures First Revenue-Generating Defense Collaboration Through BioSymetrics, Deploying AI Platform for Chemical Threat Assessment; Additional Engagements Under Discussion PR Newswire - Tue Apr 7, 8:05AM CDT

Advancing AI-enabled chemical threat detection and dual-use biodefense technologies through initial commercial deployment

LNAI : 0.3040 (-5.85%)
Lunai Bioworks Executes $20M Strategic Transaction at Fixed $1.50 Conversion, Acquiring BBB Delivery Platform for CNS Alzheimer's Therapies with Broad CNS Delivery Applications PR Newswire - Thu Mar 26, 7:50AM CDT

SACRAMENTO, Calif. , March 26, 2026 /PRNewswire/ -- Lunai Bioworks, Inc. (NASDAQ: LNAI) today announced it has executed a binding $20 million strategic transaction to acquire blood-brain barrier...

LNAI : 0.3040 (-5.85%)
Lunai Bioworks (NASDAQ: LNAI) Locks Down Core AI Architecture with U.S. Patent Enabling Precision Disease Subtyping PR Newswire - Thu Feb 19, 7:30AM CST

Foundational Patent Strengthens AI Moat Across Multimodal Data Standardization, Disease Stratification and Gene Mapping

LNAI : 0.3040 (-5.85%)
Lunai Bioworks: Fiscal Q2 Earnings Snapshot AP - Tue Feb 17, 2:22PM CST

Lunai Bioworks: Fiscal Q2 Earnings Snapshot

LNAI : 0.3040 (-5.85%)
Lunai Bioworks (NASDAQ: LNAI) Highlights Drug Discovery and Biodefense AI Platform on CNBC PR Newswire - Fri Feb 13, 7:31AM CST

SACRAMENTO, Calif. , Feb. 13, 2026 /PRNewswire/ -- Lunai Bioworks (NASDAQ: LNAI), an AI-powered biotech and biodefense company, was featured on CNBC's Business Minute . Company CEO David Weinstein...

LNAI : 0.3040 (-5.85%)
Lunai Bioworks, Inc. Issues Letter to Shareholders PR Newswire - Mon Feb 9, 10:14AM CST

SACRAMENTO, Calif.   , Feb. 9, 2026 /PRNewswire/ --

LNAI : 0.3040 (-5.85%)
Lunai Bioworks (NASDAQ: LNAI) Launches AI Oncology Pilot with Clinical-Stage Partner to Analyze Randomized Phase 2 Metastatic Colorectal Cancer Survival Trial Data PR Newswire - Mon Feb 9, 8:15AM CST

AI-driven analysis of Phase 2 survival and progression data aims to identify high-benefit patient subgroups and optimize future registrational trial strategy

LNAI : 0.3040 (-5.85%)
Lunai Bioworks (NASDAQ: LNAI) Launches Sentinel, an AI Safeguard to Block Large Language Models from Generating Novel Chemical Weapons PR Newswire - Tue Jan 27, 9:36AM CST

Transformer-based biosecurity layer embeds directly into foundation models, using Lunai's proprietary toxicology and in-vivo datasets to detect and prevent creation of previously unknown threat agents...

LNAI : 0.3040 (-5.85%)
Lunai Bioworks (NASDAQ: LNAI) Expands NIH-Funded AI Program into Commercial Alcohol Use Disorder Drug Discovery PR Newswire - Mon Jan 26, 8:30AM CST

AI Platform Achieves Key Milestones, Triggering Launch of Alcohol Use Disorder Program

LNAI : 0.3040 (-5.85%)

Barchart Exclusives

As Amazon Pours Another $25B into Data Centers, Buy This 1 High-Yield Data Center Dividend Stock Barchart - Thu Apr 16, 6:30PM CDT
Amazon’s new 25 billion dollar data‑center push underscores why American Tower’s tower network and CoreSite data‑center arm are valuable, giving investors a nearly 4% yield, discounted valuation, and direct exposure to growing cloud and AI traffic without owning a cyclical chip or hyperscaler stock. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.